Literature DB >> 8722214

Excess of rare cancers in Werner syndrome (adult progeria).

M Goto1, R W Miller, Y Ishikawa, H Sugano.   

Abstract

The association between genetic disorders and diverse cancers has provided clues for laboratory research into carcinogenesis. Such an opportunity now arises from studies of cancer in Werner syndrome (WRN). Soft-tissue sarcoma (STS) and benign meningioma have been associated with WRN, an autosomal recessive disorder characterized by premature aging, more commonly reported in Japan than elsewhere, in part because of inbreeding. In the literature we found 124 case-reports of neoplasia and WRN from Japan and 34 from outside Japan, 1939-August, 1995. They reveal a greater diversity of neoplasia in WRN than was previously known. In Japanese, there were 127 cancers, 14 benign meningioma, and 5 myeloid disorders, as compared with 30, 7 and 2 respectively in non-Japanese. The ratio of epithelial to non-epithelial cancers was about 1:1 for Japanese and for non-Japanese instead of the usual 10:1. Both series had excess of STS, osteosarcoma, myeloid disorders, and benign meningioma. In addition, the Japanese had an excess of thyroid cancer (20 versus 2 cases in non-Japanese) and melanoma (21 versus 3 cases), including 5 intranasal and 13 of the feet. STS, osteosarcoma, melanoma, and thyroid carcinoma accounted for 57% of all cancer in WRN as compared with 2% expected based on the Osaka population at 25-64 years of age. Multiple tumors were reported in 19 Japanese and 5 non-Japanese. In Japan, nine first-degree relatives had WRN and cancer, six of whom were concordant as to site and/or cell type. The WRN gene has been mapped to chromosome 8p. The high frequency of thyroid cancer and melanoma in Japanese, not found in Caucasians, may be related to a report of linkage disequilibrium with the WRN gene in Japanese but not in Caucasians and to haplotype differences within and between the two races, suggesting multiple independent mutations.

Entities:  

Mesh:

Year:  1996        PMID: 8722214

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  134 in total

1.  p53-mediated apoptosis is attenuated in Werner syndrome cells.

Authors:  E A Spillare; A I Robles; X W Wang; J C Shen; C E Yu; G D Schellenberg; C C Harris
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

2.  WRN mutations in Werner syndrome patients: genomic rearrangements, unusual intronic mutations and ethnic-specific alterations.

Authors:  Katrin Friedrich; Lin Lee; Dru F Leistritz; Gudrun Nürnberg; Bidisha Saha; Fuki M Hisama; Daniel K Eyman; Davor Lessel; Peter Nürnberg; Chumei Li; María J Garcia-F-Villalta; Carolien M Kets; Joerg Schmidtke; Vítor Tedim Cruz; Peter C Van den Akker; Joseph Boak; Dincy Peter; Goli Compoginis; Kivanc Cefle; Sukru Ozturk; Norberto López; Theda Wessel; Martin Poot; P F Ippel; Birgit Groff-Kellermann; Holger Hoehn; George M Martin; Christian Kubisch; Junko Oshima
Journal:  Hum Genet       Date:  2010-05-05       Impact factor: 4.132

3.  A novel Werner Syndrome mutation: pharmacological treatment by read-through of nonsense mutations and epigenetic therapies.

Authors:  Ruben Agrelo; Miguel Arocena Sutz; Fernando Setien; Fabian Aldunate; Manel Esteller; Valeria Da Costa; Ricardo Achenbach
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

4.  Telomere dysfunction as a cause of genomic instability in Werner syndrome.

Authors:  Laure Crabbe; Anna Jauch; Colleen M Naeger; Heidi Holtgreve-Grez; Jan Karlseder
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

5.  Functional deficit associated with a missense Werner syndrome mutation.

Authors:  Takashi Tadokoro; Ivana Rybanska-Spaeder; Tomasz Kulikowicz; Lale Dawut; Junko Oshima; Deborah L Croteau; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2013-04-11

Review 6.  The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis.

Authors:  Meltem Muftuoglu; Junko Oshima; Cayetano von Kobbe; Wen-Hsing Cheng; Dru F Leistritz; Vilhelm A Bohr
Journal:  Hum Genet       Date:  2008-09-23       Impact factor: 4.132

Review 7.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

8.  Werner syndrome protein limits MYC-induced cellular senescence.

Authors:  Carla Grandori; Kou-Juey Wu; Paula Fernandez; Celine Ngouenet; Jonathan Grim; Bruce E Clurman; Michael J Moser; Junko Oshima; David W Russell; Karen Swisshelm; Scott Frank; Bruno Amati; Riccardo Dalla-Favera; Raymond J Monnat
Journal:  Genes Dev       Date:  2003-07-01       Impact factor: 11.361

9.  Inflammageing assessed by MMP9 in normal Japanese individuals and the patients with Werner syndrome.

Authors:  Makoto Goto; Junji Chiba; Masaaki Matsuura; Sachiko Iwaki-Egawa; Yasuhiro Watanabe
Journal:  Intractable Rare Dis Res       Date:  2016-05

10.  Displacement of DNA-PKcs from DNA ends by the Werner syndrome protein.

Authors:  Baomin Li; Lucio Comai
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.